-
1
-
-
80051585203
-
-
Centers for Disease Control 2011 National Diabetes Fact Sheet. Accessed on April 25, 2011
-
Centers for Disease Control 2011 National Diabetes Fact Sheet. Accessed on April 25, 2011 at http://www.cdc.gov/diabetes/pubs/pdf/ndfs-2011.pdf
-
-
-
-
2
-
-
0022347471
-
Photocoagulation for diabetic macular edema: Early Treatment Diabetic Retinopathy Study report number 1
-
Early Treatment Diabetic Retinopathy Study Research Group
-
Early Treatment Diabetic Retinopathy Study Research Group 1985 Photocoagulation for diabetic macular edema: Early Treatment Diabetic Retinopathy Study report number 1 Arch Ophthalmol 103 1796 1806
-
(1985)
Arch Ophthalmol
, vol.103
, pp. 1796-1806
-
-
-
3
-
-
29644444716
-
Changes in retinal neovascularization after pegaptanib (Macugen) therapy in diabetic individuals
-
DOI 10.1016/j.ophtha.2005.10.012, PII S0161642005011863
-
Macugen Diabetic Retinopathy Study Group 2006 Changes in retinal neovascularization after pegaptanib (Macugen) therapy in diabetic individuals Ophthalmology 113 23 28 10.1016/j.ophtha.2005.10.012 (Pubitemid 43021723)
-
(2006)
Ophthalmology
, vol.113
, Issue.1
, pp. 23-28
-
-
Bressler, N.M.1
Altaweel, M.2
-
4
-
-
70350567637
-
READ-2 Study Group. Primary end point (six months) results of the Ranibizumab for Edema of the mAcula in Diabetes (READ-2) Study
-
19700194 10.1016/j.ophtha.2009.04.023
-
QD Nguyen SM Shah JS Heier, et al. 2009 READ-2 Study Group. Primary end point (six months) results of the Ranibizumab for Edema of the mAcula in Diabetes (READ-2) Study Ophthalmology 116 2175 2181 19700194 10.1016/j.ophtha.2009.04.023
-
(2009)
Ophthalmology
, vol.116
, pp. 2175-2181
-
-
Nguyen, Q.D.1
Shah, S.M.2
Heier, J.S.3
-
5
-
-
7444245438
-
Intravitreal triamcinolone for diabetic macular edema that persists after laser treatment: Three-month efficacy and safety results of a prospective, randomized, double-masked, placebo-controlled clinical trial
-
DOI 10.1016/j.ophtha.2004.05.025, PII S0161642004009248
-
FK Sutter JM Simpson MC Gillies 2004 Intravitreal triamcinolone for diabetic macular edema that persists after laser treatment: three-month efficacy and safety results of a prospective, randomized, double-masked, placebo-controlled clinical trial Ophthalmology. 111 11 2044 2049 15522370 10.1016/j.ophtha.2004.05.025 (Pubitemid 39446723)
-
(2004)
Ophthalmology
, vol.111
, Issue.11
, pp. 2044-2049
-
-
Sutter, F.K.P.1
Simpson, J.M.2
Gillies, M.C.3
-
6
-
-
0028120906
-
Collaborative overview of randomised trials of antiplatelet therapy-I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients
-
Antiplatelet Trialists' Collaboration
-
Antiplatelet Trialists' Collaboration 1994 Collaborative overview of randomised trials of antiplatelet therapy-I: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients BMJ 308 81 106
-
(1994)
BMJ
, vol.308
, pp. 81-106
-
-
-
7
-
-
79953299899
-
Expanded 2-Year Follow-up of Ranibizumab Plus Prompt or Deferred Laser or Triamcinolone Plus Prompt Laser for Diabetic Macular Edema
-
Diabetic Retinopathy Clinical Research Network; Writing Committee Apr
-
Diabetic Retinopathy Clinical Research Network; Writing Committee, Elman MJ, Bressler NM, Qin H, Beck RW, Ferris FL 3rd, Friedman SM, Glassman AR, Scott IU, Stockdale CR, Sun JK. Expanded 2-Year Follow-up of Ranibizumab Plus Prompt or Deferred Laser or Triamcinolone Plus Prompt Laser for Diabetic Macular Edema. Ophthalmology. 2011 Apr;118(4):609-14.
-
(2011)
Ophthalmology
, vol.118
, Issue.4
, pp. 609-614
-
-
Elman, M.J.1
Bressler, N.M.2
Qin, H.3
Beck, R.W.4
Ferris Iii, F.L.5
Friedman, S.M.6
Glassman, A.R.7
Scott, I.U.8
Stockdale, C.R.9
Sun, J.K.10
|